AI interpretation based on checked source excerpts. Issuer assertions and evidence limitations remain explicit.
Policy quality-scores-2: six equally weighted categories. The overall score requires full coverage. Missing inputs are not zero. Qualitative grades are sourced interpretations, not probabilities. 5/6 · 18/10/2026
Moat—
Insufficient evidence for every rubric criterion; no category score is inferred.
structural advantage · — · Brands, intellectual property and distribution provide plausible differentiation, but their competitive superiority and economic protection are not established. The uncertain verdict requires an ungraded moat assessment.
durability · — · The passages do not establish sustained brand premiums or market-share protection. Historical impairments show localized fragility without resolving company-wide durability.
customer dependency · — · Volume growth demonstrates demand, but customer dependence on Kimberly-Clark, switching friction and exclusive access are not established. Retailer concentration also creates dependence in the opposite direction.
erosion resilience · — · Productivity savings and demand growth coexist with pricing pressure and realized China sales disruption. The evidence cannot establish resilience of an underlying structural advantage.
Pricing power44
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
realized pricing · 1/4 · Earlier price increases supported earnings, and 2024 pricing rose 1.9%, primarily in hyperinflationary economies. However, 2025 pricing declined and first-half 2026 pricing was unfavorable relative to inflation. Current demonstrated pricing power is fragile.
retention · 2/4 · Indirect demand evidence is mixed: 2025 volume grew 2.5% and first-quarter 2026 volume grew 2.6%, but earlier pricing caused volume elasticity and China suffered a significant sales disruption. These are operating indicators, not measured customer retention.
margin resilience · 2/4 · First-half 2026 adjusted gross margin increased 60 basis points, supported by approximately $235 million of productivity savings and one-time tariff refunds. Unfavorable pricing relative to inflation and supply-chain investment offset part of those gains, so margin resilience does not demonstrate strong pricing power.
contractual freedom · 2/4 · Disclosed practices establish an ability to adjust product prices based on demand, competition and costs. That discretion is economically constrained by retailer bargaining power and substantial customer concentration; detailed contractual repricing rights are unavailable.
Predictability85
Five consecutive annual periods. Equal weights: nondeclining revenue frequency; revenue-growth volatility (5–40pp); positive FCF frequency; FCF-margin volatility (3–20pp). Stability indicator, not a growth forecast.
- Nondeclining revenue years (%)
- 50.00
- Revenue growth volatility (pp)
- 8.50
- Positive FCF years (%)
- 100.00
- FCF margin volatility (pp)
- 1.88
Financial strength43
Equal-weight grades: debt/FCF (1–8x), net debt/earnings before interest and tax (0–5x), interest service (1–12x), current ratio (0.75–2x). Earnings use reported operating income, or reported pretax profit plus reported interest expense when operating income is unavailable. Interest service uses earnings/interest expense; if unavailable, it uses reported operating cash flow/cash interest paid, without relabeling cash paid as accrued expense. Nonpositive cash flow/earnings score 0 for their service component; reported zero interest with a positive numerator scores 100. Net cash scores 100 for net leverage. Missing disclosures remain unavailable. General nonfinancial-company rubric, not a credit rating; exceptional and nonoperating gains are not normalized out. IFRS finance-cost and cash-flow classifications retain their reported scope.
- debtFcfGrade
- 51.81
- netDebtEbitGrade
- 44.87
- interestCoverageGrade
- 74.40
- currentRatioGrade
- 0.00
- Debt / FCF (x)
- 4.37
- Net debt / operating income (x)
- 2.76
- Interest coverage (x)
- 9.18
- Current ratio (x)
- 0.75
Capital allocation100
Three-year equal-weight indicators: pretax return on average invested capital (0–25%; equity + debt − cash, each year and its prior year), share-count growth (0–5%, lower better), share-based cost/revenue (2–20%, lower better), consolidated FCF/net income (0–1x). Return uses reported operating income or, if unavailable, EBIT calculated from reported pretax profit plus reported interest expense; exceptional/nonoperating gains are not normalized out. Share-based cost uses the reported cash-flow add-back or, if absent, separately reported recognized compensation expense; the latter never becomes an FCF adjustment. Nonpositive net income scores 0 for cash conversion; absent income/FCF stays unavailable. Nonpositive invested capital has no defined return and remains unavailable. Does not establish acquisition quality or buyback timing.
- 3-year pre-tax operating return (%)
- 33.43
- 3-year average dilution (%)
- -0.55
- 3-year average SBC / revenue (%)
- 0.78
- cashConversionGrade
- 100.00
Management63
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
capital discipline · 2/4 · Cash generation funded substantial investment, and first-half 2026 repurchases ceased while capital spending increased. Counterweights include declining 2023–2025 operating cash flow, acquisition impairments, new financing and substantial pending Kenvue stock-and-cash commitments. The recent cash-flow increase partly reflects insurance recovery and working-capital timing; acquisition returns remain unproven.
incentive alignment · 3/4 · Actual 2025 grants allocated 60% of target value to performance-based units and 40% to time-vested units. Performance vesting depends on three-year organic growth and cumulative modified free cash flow. This demonstrates meaningful alignment, tempered by committee adjustment discretion and absent individual executive ownership detail. Future vesting is not treated as completed.
execution · 2/4 · Demonstrated productivity savings, volume growth and completed IFP disposal support execution. Counterweights include missed 2025 incentive targets, historical acquisition underperformance and extension of the transformation from 2026 to 2028. The reported 95% savings milestone combines realized savings with approved actions and cannot be treated as fully delivered.
governance · 3/4 · Actual disclosures establish 12 of 13 independent directors, independent key committees, special-meeting and proxy-access rights, and director attendance above 75%. The combined chairman and CEO role limits separation of authority. These support strong governance structures and participation without proving exceptional oversight outcomes.
Evidence
Our products are sold under well-known brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend.
MD&A / brands · Filed 04/08/2026
We own various patents and trademarks registered domestically and in many foreign countries.
Business / patents and trademarks · Filed 13/02/2025
The principal methods and elements of competition include brand recognition and loyalty, product innovation, quality and performance, price, and marketing and distribution capabilities.
Business / elements of competition · Filed 08/02/2024
Distribution and Customers Our essential products for household use are sold directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores and other retail outlets, as well as through other distributors and e-commerce.
Business / distribution and customers · Filed 12/02/2026
The introduction of a new consumer product (whether improved or newly developed) usually requires substantial expenditures for advertising and marketing to gain recognition in the marketplace.
Risk factors / product introduction and marketing expenditures · Filed 12/02/2026
If a product gains consumer acceptance, it normally requires continued advertising and promotional support to maintain its relative market position.
Risk factors / continuing promotional support · Filed 12/02/2026
With the consolidation of retail trade, both traditional retailers and e-tailers, we are dependent on key customers, and some of these customers, including large-format retailers and large e-tailers, may have significant bargaining power.
Risk factors / retailer bargaining power · Filed 12/02/2026
While we are effectively navigating the situation, the impact from the spread of false claims across social media significantly impacted our diaper sales in China in the second quarter of 2026 and is expected to further impact sales and profits in the near term.
MD&A / China diaper sales disruption · Filed 04/08/2026
These reviews and the subsequent revisions in the projections highlighted challenges for the Softex business arising from modified consumer shopping behavior in the post-COVID-19 period, inflationary pressures and other macroeconomic factors and increased competitive activity in the region.
Intangible assets / Softex competitive challenges · Filed 12/02/2026
As a result of separate management reviews, we also have revised internal financial projections associated with our acquisition of a controlling interest in Thinx as a result of performance below expectations due to the impact of modified consumer shopping behavior in the post-COVID-19 period.
Intangible assets / Thinx performance below expectations · Filed 12/02/2026
As a result of the interim impairment assessments, we recognized impairment charges, principally arising from the impairment charge of $593 related to the Softex business, totaling $658 pre-tax ($483 after-tax) to write-down these intangible assets to their respective fair values aggregating to $188 as of June 30, 2023.
Intangible assets / 2023 impairment charges · Filed 12/02/2026
Excluding these items, organic growth was 3.2% driven by a 1.9% increase in price, primarily in hyperinflationary economies, coupled with volume and mix gains across all three reportable segments.
MD&A / 2024 organic growth and pricing · Filed 13/02/2025
Organic sales increased 1.7% driven by volume gains of 2.5%, partially offset by lower pricing.
MD&A / 2025 volume growth and lower pricing · Filed 12/02/2026
Results benefited from higher net selling prices, $325 of cost savings from our FORCE program, and improved product mix, partially offset by higher marketing, research and general expenses, unfavorable foreign currency effects, higher other manufacturing costs, lower volumes and higher input costs.
MD&A / 2023 operating profit drivers · Filed 08/02/2024
Net sales of $3.4 billion increased 5 percent compared to the year ago period, while organic sales increased 7 percent driven by changes in net selling prices and product mix of 10 percent and 1 percent, respectively, partially offset by lower volumes of 5 percent.
Segment results / pricing, mix and volume · Filed 08/02/2024
The decrease in volumes primarily reflected expected elasticity from pricing actions.
Segment results / realized pricing elasticity · Filed 08/02/2024
Organic sales increased 2.5% primarily from volume gains of 2.6%.
MD&A / first-quarter 2026 organic sales and volume · Filed 28/04/2026
Net sales of $4.2 billion for the three months ended June 30, 2026 increased 0.6% primarily driven by favorable currency impacts, while organic sales growth was relatively flat compared to the prior year, including an approximately 50 basis point negative impact from the China social media disruption.
MD&A / second-quarter 2026 sales and China disruption · Filed 04/08/2026
Excluding these charges, adjusted gross margin increased 60 basis points to 38.3%.
MD&A / first-half 2026 adjusted gross margin · Filed 04/08/2026
The increase was primarily due to one-time tariff refunds and gross productivity savings from integrated margin management of approximately $235, partially offset by supply chain related investments and unfavorable pricing net of cost inflation.
MD&A / productivity, tariff refunds and unfavorable pricing · Filed 04/08/2026
We adjust our product prices based on a number of variables including demand, the competitive environment, technological improvements, product innovations and changes in our raw material, distribution, energy and other input costs.
MD&A / product price-setting practices · Filed 12/02/2026
Our largest customer, Walmart Inc., represented approximately 16% in 2025 and 2024 and 15% in 2023 of our net sales from continuing operations.
Business / customer concentration in continuing operations · Filed 12/02/2026
The following table provides a reconciliation of Adjusted Free Cash Flow: Year Ended December 31 (in millions) 2025 2024 2023 Cash Provided by Operations $ 2,777 $ 3,234 $ 3,542 Capital Expenditures (1,138) (721) (766) Cash Restructuring Charges 229 156 — IFP Separation Costs 35 — — Adjusted Free Cash Flow $ 1,903 $ 2,669 $ 2,776 A-3 2026 Proxy Statement Invitation to Stockholders Notice of 2026 Annual Meeting Proxy Statement
Appendix A / operating cash flow and capital expenditures · Filed 23/03/2026
5 KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Six Months Ended June 30 (In millions) 2026 2025 Operating Activities Net income $ 1,025 $ 1,085 Depreciation and amortization 360 440 Stock-based compensation 64 73 Deferred income taxes (83) (30) Net (gains) losses on asset and business dispositions (7) 36 Equity companies' earnings (in excess of) less than dividends paid (65) (50) Operating working capital 399 (471) Postretirement benefits (2) 9 Other (38) 5 Cash Provided by Operations 1,653 1,097 Investing Activities Capital spending (776) (401) Proceeds from asset and business dispositions 28 12 Investments in time deposits (166) (227) Maturities of time deposits 132 282 Other 17 22 Cash Used for Investing (765) (312) Financing Activities Cash dividends paid (843) (824) Change in short-term debt (252) 51 Debt proceeds 1,329 — Debt repayments (400) (250) Proceeds from exercise of stock options — 36 Repurchases of common stock — (120) Cash dividends paid to noncontrolling interests (15) (18) Other (41) (58) Cash Used for Financing (222) (1,183) Effect of Exchange Rate Changes on Cash and Cash Equivalents (4) 34 Change in Cash and Cash Equivalents 662 (364) Cash and cash equivalents from continuing operations - beginning of period 688 1,010 Cash and cash equivalents from discontinued operations - beginning of period(a) 13 11 Cash and Cash Equivalents - Beginning of Period 701 1,021 Cash and cash equivalents from continuing operations - end of period 956 634 Cash and cash equivalents from discontinued operations - end of period(a) 407 23 Cash and Cash Equivalents - End of Period $ 1,363 $ 657 (a) Included in Current assets of discontinued operations.
Consolidated cash flows / first-half 2026 spending and financing · Filed 04/08/2026
The increase was driven primarily by an insurance recovery associated with the settlement of claims from a previous acquisition and favorable changes in operating working capital, due in part to timing and lower incentive payments in the current year.
Liquidity / insurance recovery and working-capital timing · Filed 04/08/2026
In total, we expect approximately 280 million shares of common stock to be issued and approximately $6.7 billion to be paid for the Merger Consideration.
Pending acquisition / expected stock issuance and cash consideration · Filed 12/02/2026
Completion of the Kenvue Acquisition, which is expected to take place in the second half of 2026, remains subject to the satisfaction of other customary closing conditions, as described in the Merger Agreement, including the receipt of foreign regulatory approvals.
Acquisitions / pending Kenvue closing conditions · Filed 04/08/2026
Target grant values were approved in February 2025 and were divided into two types: •Performance-based restricted share units (60 percent of the target grant value) which will vest on the third anniversary of the grant date.
Compensation / approved February 2025 performance-based grants · Filed 23/03/2026
•Time-vested restricted share units (40 percent of the target grant value) which will vest in three annual installments of 30 percent, 30 percent and 40 percent beginning on the first anniversary of the grant date.
Compensation / time-vested grant allocation · Filed 23/03/2026
The number of performance-based restricted share units granted in 2025 that will ultimately vest on the third anniversary of the grant date could range from the threshold number to the maximum number depending on the extent to which the average annual organic sales growth and cumulative modified free cash flow performance objectives for those awards are met.
Compensation / performance award vesting conditions · Filed 23/03/2026
Under the Committee’s exception guidelines regarding our annual and long-term equity incentive program measures, the Committee has adjusted in the past, and may adjust in the future, the calculation of financial measures for these incentive programs to eliminate the effect of the types of items or events described above.
Compensation / committee adjustments to performance measures · Filed 23/03/2026
Performance Measure 2025 Results 2025 Target Organic sales growth* 1.1 % 2.5 % Adjusted EPS** $ 7.37 $ 7.56 * Organic sales growth and Adjusted EPS are non-GAAP financial measures.
Compensation / 2025 financial results versus incentive targets · Filed 23/03/2026
During the second quarter of 2026, our Board of Directors approved an extension of the 2024 Transformation Initiative through the end of 2028.
Transformation / board-approved extension through 2028 · Filed 04/08/2026
The 2024 Transformation Initiative is expected to be completed by the end of 2026, with total costs anticipated to be approximately $1.5 billion pre-tax.
Transformation / earlier expected completion by end of 2026 · Filed 28/04/2026
Through June 30, 2026, cumulative pre-tax charges for the 2024 Transformation Initiative were $913 ($706 after-tax), and approximately 95% of the total expected selling, general and administrative expense savings have been realized or approved for action program to date.
Transformation / cumulative charges and savings realized or approved · Filed 04/08/2026
88 2026 Proxy Statement Proposal 4 – Stockholder proposal to require independent board chair In addition to the strong Independent Lead Director role, our Board structure and corporate governance practices demonstrate our commitment to effective governance and accountability to our stockholders, including: •a majority of our directors (12 out of 13) are independent; •all of the members and Chairs of the Audit Committee, Management Development and Compensation Committee and Nominating and Corporate Governance Committee are independent; •the Board and each Board committee have the authority to hire independent legal, financial or other advisors at the company's expense; •our independent directors hold regular meetings in executive sessions to discuss matters important to the company, including matters related to management; •our stockholders have access to strong stockholder rights, including the right to call a special meeting of stockholders and proxy access; and •we regularly engage with investors to understand their perspective on a variety of topics, including our approach to director refreshment, our corporate governance practices, and our executive compensation program.
Governance / board independence, committees and stockholder rights · Filed 23/03/2026
Chairman and CEO Positions The Board’s current view is that a combined Chairman and CEO position, coupled with a predominantly independent board and a proactive, independent Lead Director, promotes candid discourse, informed business considerations and responsible corporate governance.
Governance / combined chairman and CEO · Filed 23/03/2026
All of the directors attended in excess of 75 percent of the total number of meetings of the Board and the committees on which they served.
Governance / actual director meeting attendance · Filed 23/03/2026
E-commerce potentially intensifies competition by simplifying distribution and lowering barriers to entry.
Risk factors / potential e-commerce entry-barrier reduction · Filed 08/02/2024
On July 1, 2026, all consultation requirements and customary closing conditions set forth in the Purchase Agreement were satisfied and the IFP Transaction was completed for a cash purchase price of approximately $1.3 billion, subject to certain post-closing adjustments.
Subsequent event / completed IFP transaction · Filed 04/08/2026
